FDA Approved: LACOSAMIDE — Supplemental Application (Glenmark Pharmaceuticals Inc. USA)

View source ↗

Summary

FDA approved a supplemental application for lacosamide from Glenmark Pharmaceuticals USA, enabling continued generic lacosamide under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)